Back to top

$REPL stock is up 12% today. Here's what we see in our data.

$REPL stock has now risen 12% today, according to our price data from Polygon. There has been approximately $33,719,500 of trading volume.

It has been the 328th most-searched ticker on Quiver Quantitative over the last day, out of 11,620 total tickers searched.

Here is what we see in our data on $REPL (you can track the company live on Quiver's $REPL stock page):

$REPL Insider Trading Activity

REPL Insider Trades

$REPL insiders have traded $REPL stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $REPL stock by insiders over the last 6 months:

  • CHRISTOPHER SARCHI (Chief Commercial Officer) has made 0 purchases and 3 sales selling 27,126 shares for an estimated $206,765.
  • SUSHIL PATEL (Chief Executive Officer) sold 37,324 shares for an estimated $189,605
  • PHILIP ASTLEY-SPARKE sold 17,657 shares for an estimated $89,697
  • KONSTANTINOS XYNOS (Chief Medical Officer) sold 14,023 shares for an estimated $71,236
  • ANDREW SCHWENDENMAN (Chief Accounting Officer) sold 7,894 shares for an estimated $40,101
  • EMILY LUISA HILL (Chief Financial Officer) sold 7,812 shares for an estimated $39,684

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$REPL Hedge Fund Activity

We have seen 129 institutional investors add shares of $REPL stock to their portfolio, and 83 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • SUVRETTA CAPITAL MANAGEMENT, LLC added 4,185,798 shares (+11615.0%) to their portfolio in Q1 2026, for an estimated $32,021,354
  • BLACKROCK, INC. added 2,719,296 shares (+43.6%) to their portfolio in Q2 2026, for an estimated $30,102,606
  • GOLDMAN SACHS GROUP INC added 1,619,180 shares (+246.0%) to their portfolio in Q1 2026, for an estimated $12,386,727
  • COMMODORE CAPITAL LP removed 1,425,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $10,901,250
  • ROSALIND ADVISORS, INC. removed 1,410,497 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $10,790,302
  • REDMILE GROUP, LLC removed 1,099,756 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,413,133
  • ECOR1 CAPITAL, LLC added 1,000,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $7,650,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS
Receive REPL Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$REPL Analyst Ratings

Wall Street analysts have issued reports on $REPL in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

  • JP Morgan issued a "Underweight" rating on 04/13/2026
  • HC Wainwright & Co. issued a "Sell" rating on 04/13/2026

To track analyst ratings and price targets for $REPL, check out Quiver Quantitative's $REPL forecast page.

$REPL Price Targets

Multiple analysts have issued price targets for $REPL recently. We have seen 3 analysts offer price targets for $REPL in the last 6 months, with a median target of $2.0.

Here are some recent targets:

  • Robert Driscoll from Wedbush set a target price of $9.0 on 06/30/2026
  • Roger Song from Jefferies set a target price of $2.0 on 04/13/2026
  • Jonathan Chang from Leerink Partners set a target price of $2.0 on 04/13/2026

You can track data on $REPL on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Replimune Group, Inc. (REPL)